Home
Contact us
LinkedIn

Company
Our Science
Clinical Trials
News
- Press Releases
- Events
Contact
- Contact us
- Careers

Company
Our Science
Clinical Trials
News
- Press Releases
- Events
Contact
- Contact us
- Careers

Home / Archives for November 2020

Month: November 2020

Invectys’ CARGo project: $14.2M 2020 CPRIT Award

Invectys well poised to bring its anti-HLA-G CAR-T cells to clinical trials …

Founded in 2010 out of the Pasteur Institute, Invectys is a biopharmaceutical company focused on the development of innovative immunotherapy approaches to treat cancer with its headquarters in Houston, Texas and Research & Innovation center in Paris.

Invectys exploits a novel approach to mobilizing and restoring the anti-tumor capacity of the immune system of cancer patients. This allows virtually all cancers to be targeted. Invectys focuses its efforts on two platforms: 1) HLA-G, a powerful immune checkpoint and a tumor specific antigen; 2) the universal tumor antigen telomerase (TERT) that is critical to uncontrolled cell growth.

Menu

Contact us
Legal notices
Press Releases

Contact US

Invectys Inc.
2415 West Alabama,
Suite 220, Houston,
TX 77098, USA

Follow US

LinkedIn

Credits

Communication and editorial: Acorelis
Graphic creation and development: 17Pixel.com

Copyright © 2024 Invectys